Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Gas Analyzers Have New Compliance Capabilities

By LabMedica International staff writers
Posted on 23 Jan 2011
Blood gas analyzers have been enhanced and redesigned for low-to-mid- volume hospital and reference laboratories.

Quality Control (QC) information can be scanned into the system using simple barcode technology, increasing convenience for operators and minimizing opportunity for error. More...
The new applications conform specifically to the Guidelines of the German Federal Medical Council (RiliBAK) rules and Analytical Measurement Ranges, which helps to simplify the regulatory compliance process in select areas of the world.

The new enhancements are found on the RAPIDPoint 340/350 Blood Gas Analyzers enabling users to scan all quality control lot numbers and corresponding mean and standard deviation limits into the analyzer prior to running the ampouled QC. As quality control samples are analyzed, QC results for up to three levels per day, for a total of 31 days, are stored in the appropriate quality control folder on the instrument.

The RAPIDPoint 300 system produced by Siemens Healthcare Diagnostics, (Deerfield, IL, USA), can be configured so that the analytical measurement ranges for each parameter ensuring that patient results are provided only for values that have been validated according to the calibration verification material tested. A new faster and quieter printer completes the package of convenient features

David Stein, PhD, CEO, Point-of-Care Business Unit, Siemens Healthcare Diagnostics, said, "As hospital workloads increase, it is important to continually improve laboratory efficiencies and processes particularly in light of the cost containment and staffing challenges clinical laboratories face today. These latest enhancements to our blood gas systems were designed with that goal in mind."

Related Links:
Siemens Healthcare Diagnostics


Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Autoimmune Liver Diseases Assay
Microblot-Array Liver Profile Kit
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.